DERM logo

Journey Medical Corporation

DERM
Healthcare|Drug Manufacturers - Specialty & Generic|US
$4.47
+0.17 (+3.95%)
Tangible Book / Share
$0.24
Cash / Share
$0.93

About

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

Stock Price

-51.4%(1Y)
1M
-24.9%
3M
-30.5%
6M
-11.8%
YTD
-42.0%
1Y
-50.1%
3Y
+18.9%
5Y
-52.9%

Pipeline Summary

12 total trials
2
Phase 1
3
Phase 2
5
Phase 3
0
Phase 4
Completed: 10Not Yet Recruiting: 2

Key Facts

Market Cap$126.2M
Employees58 (+41% YoY)
CEOClaude Maraoui
IPO DateNov 12, 2021
Beta1.15
52-Week Range$4.25 – $9.56
Avg Volume187,132
ExchangeNASDAQ

Ownership

Float51.5%
Shares Outstanding28.2M

Recent Insider Trades

Toledano Miranda JayneAWARD
Jul 1, 202650,000 shares
Smith Justin AdamAWARD
Jul 1, 202650,000 shares
Herskowitz NeilAWARD
Jul 1, 202650,000 shares
Toledano Miranda JayneAWARD
Jun 25, 202610,000 shares
Smith Justin AdamAWARD
Jun 25, 202610,000 shares

Peers

FENCFennec Pharmaceuticals Inc.
$344.0M
HSDTSolana Company
$112.7M
IVAInventiva S.A.
$197.5M
MDWDMediWound Ltd.
$184.0M
NYXHNyxoah S.A.
$86.1M
OBIOOrchestra BioMed Holdings, Inc.
$341.4M
OGIOrganigram Global Inc.
$123.6M
OSUROraSure Technologies, Inc.
$237.3M
Data last updated: Nov 9, 2026, 04:06 AM